drugset / Trial / NCT01214382

Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery

NCT01214382

NaSingle-groupOpen-label

Summary

This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.

Timeline

Start
2010-10
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg

Indications

No indication recorded.